1. Home
  2. GOOS vs LXRX Comparison

GOOS vs LXRX Comparison

Compare GOOS & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canada Goose Holdings Inc. Subordinate Voting Shares

GOOS

Canada Goose Holdings Inc. Subordinate Voting Shares

HOLD

Current Price

$8.22

Market Cap

931.6M

Sector

N/A

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$2.24

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOOS
LXRX
Founded
1957
1995
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
931.6M
1.0B
IPO Year
2016
2000

Fundamental Metrics

Financial Performance
Metric
GOOS
LXRX
Price
$8.22
$2.24
Analyst Decision
Hold
Strong Buy
Analyst Count
5
2
Target Price
$12.60
$4.15
AVG Volume (30 Days)
719.9K
2.6M
Earning Date
05-20-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.78
EPS
N/A
N/A
Revenue
N/A
$49,803,000.00
Revenue This Year
$12.21
N/A
Revenue Next Year
$5.16
N/A
P/E Ratio
$75.22
N/A
Revenue Growth
N/A
60.24
52 Week Low
$8.05
$1.05
52 Week High
$14.69
$2.68

Technical Indicators

Market Signals
Indicator
GOOS
LXRX
Relative Strength Index (RSI) 38.46 46.87
Support Level $8.05 $2.17
Resistance Level $10.42 $2.49
Average True Range (ATR) 0.21 0.09
MACD 0.00 -0.01
Stochastic Oscillator 19.05 27.87

Price Performance

Historical Comparison
GOOS
LXRX

About GOOS Canada Goose Holdings Inc. Subordinate Voting Shares

Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale; Direct to Consumer (DTC), and Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia-Pacific, and Europe, the Middle East, and Africa.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: